Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 196

Sort by

Sort Order Select

Journal Articles

Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study

Alma R. Oskarsdottir, Brynja R. Gudmundsdottir, Hulda M. Jensdottir, Bjorn Flygenring, Ragnar Palsson, Pall T. Onundarson

Blood (2021) 137 (20): 2745–2755.

https://doi.org/10.1182/blood.2020008698

Published: 2021

Includes: Supplemental data

Journal Articles

Clinical, Laboratory and Molecular Characterization of Factor VII, Factor X and Their Combined Deficiencies in a Tertiary Care Center

Bereczky Zsuzsanna, MD PhD, Speker Marianna, Al-Muhanna Marie, Balogh Gábor, Boda Zoltán, MD PhD DSc, Pfliegler György, MD PhD, Schlammadinger Ágota, MD PhD, Kerényi Adrienn, MD PhD, Csongor Kiss, MD PhD DSc

Blood (2019) 134 (Supplement_1): 2394.

https://doi.org/10.1182/blood-2019-125504

Published: 2019

Journal Articles

Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes

Grace A Ward, BS, Kathy McGraw, PhD, Amy F McLemore, M.S., Nghi B Lam, M.S., Hsin-An Hou, Benjamin S. Meyer, Alan F. List, MD

Blood (2019) 134 (Supplement_1): 774.

https://doi.org/10.1182/blood-2019-122358

Published: 2019

Journal Articles

Monitoring of Recombinant Activated Coagulation Factor VII (rFVIIa) Therapy in Patients (pts) with Inherited Factor VII (FVII) Deficiency

Gennadii M. Galstian, Olesya A. Polevodova, MD, Elena Yakovleva, MD PhD, Antonina Shchekina, MD, Igor Davydkin, MD PhD, Dmitriy Kudlay, MD PhD

Blood (2019) 134 (Supplement_1): 2412.

https://doi.org/10.1182/blood-2019-124709

Published: 2019

Journal Articles

Barriers to Care Amongst Patients with Inherited Bleeding Disorders: Results from Two Nation-Wide Canadian Surveys

Sumedha Arya, MD BSc, Pamela Wilton, RN, CRE, David Page, Laurence Boma-Fischer, PT, MSc, Georgina Floros, RN, Katie Dainty, PhD, Rochelle Winikoff, MD FRCPC, Michelle Sholzberg, MDBSc,FRCPC,MSc

Blood (2019) 134 (Supplement_1): 4704.

https://doi.org/10.1182/blood-2019-126288

Published: 2019

Journal Articles

Platelet Function Disorder Is More Common Than Von Willebrand Disease in Women with Inherited Bleeding Disorders: Report from a Public Sector University in Pakistan

Nazli Hossain, Sr., Tahir S. Shamsi, MBBS,FRCPath, Arshi Naz, Sidra Abbas, Jr., Nazeer Khan

Blood (2019) 134 (Supplement_1): 4937.

https://doi.org/10.1182/blood-2019-126454

Published: 2019

Journal Articles

A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology

Paul S. de Vries, Maria Sabater-Lleal, Jennifer E. Huffman, Jonathan Marten, Ci Song, Nathan Pankratz, Traci M. Bartz, Hugoline G. de Haan, Graciela E. Delgado, John D. Eicher, Angel Martinez-Perez, Cavin K. Ward-Caviness, Jennifer A. Brody, Ming-Huei Chen, Moniek P. M. de Maat, Mattias Frånberg, Dipender Gill, Marcus E. Kleber, Fernando Rivadeneira, José Manuel Soria, Weihong Tang, Geoffrey H. Tofler, André G. Uitterlinden, Astrid van Hylckama Vlieg, Sudha Seshadri, Eric Boerwinkle, Neil M. Davies, Anne-Katrin Giese, M. Kamran Ikram, Steven J. Kittner, Barbara McKnight, Bruce M. Psaty, Alex P. Reiner, Muralidharan Sargurupremraj, Kent D. Taylor, INVENT Consortium, MEGASTROKE Consortium of the International Stroke Genetics Consortium, Myriam Fornage, Anders Hamsten, Winfried März, Frits R. Rosendaal, Juan Carlos Souto, Abbas Dehghan, Andrew D. Johnson, Alanna C. Morrison, Christopher J. O'Donnell, Nicholas L. Smith

Blood (2019) 133 (9): 967–977.

https://doi.org/10.1182/blood-2018-05-849240

Published: 2019

Includes: Supplemental data

Journal Articles

Replacing PT-INR Monitoring of Warfarin with Fiix-NR in Clinical Practice Reduces Thromboembolism without Increasing Bleeding Despite Reduced Number of Dose Adjustments

Alma R. Oskarsdottir, MD, Brynja R. Gudmundsdottir, MS, Pall T. Onundarson, MD

Blood (2018) 132 (Supplement 1): 1239.

https://doi.org/10.1182/blood-2018-99-116731

Published: 2018

Journal Articles

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Madhvi Rajpurkar, MD, Stacy E. Croteau, MD, Lisa N Boggio, MD MS, David L Cooper, MD

Blood (2018) 132 (Supplement 1): 1203.

https://doi.org/10.1182/blood-2018-99-115153

Published: 2018

Journal Articles

Recombinant Activated Coagulation Factor VII (rFVIIa) for Treatment of the Tracheobronchial Bleeding in Mechanically Ventilated (MV) Thrombocytopenic Patients (pts)

Gennadii M. Galstian, Olesya A. Polevodova, MD, Vladimir Yu. Zorenko, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2018) 132 (Supplement 1): 2446.

https://doi.org/10.1182/blood-2018-99-115685

Published: 2018

Journal Articles

The Chemical Chaperone 4-Phenylbutyrate Increases Secretion and Activity of Missense and Elongated Factor VII Mutants

Elisabeth Andersen, MSc, Maria Eugenia Chollet, Marcello Baroni, Mirko Pinotti, Francesco Bernardi, Ellen Skarpen, Per Morten Sandset, Grethe Skretting

Blood (2018) 132 (Supplement 1): 3777.

https://doi.org/10.1182/blood-2018-99-118246

Published: 2018

Journal Articles

Arsenic Trioxide Induces Apoptosis and Regulatory Functions of Plasmacytoid Dendritic Cells

Yishan Ye, MD, Laure Ricard, MD, Nicolas Stocker, MD, Baptiste Lamarthée, PhD, Frédéric De Vassoigne, Eolia Brissot, MDPhD, Arsène Mekinian, MDPhD, Mohamad Mohty, MD PhD, Béatrice Gaugler, PhD, Florent Malard, MDPhD

Blood (2018) 132 (Supplement 1): 514.

https://doi.org/10.1182/blood-2018-99-110717

Published: 2018

Journal Articles

Providing Hemostasis for Long-Term Central Venous Access Device (LTCVAD) Placement in Patients with Factor VIII (FVIII) Inhibitors

Gennadii M. Galstian, Michail Spirin, MD, Nadezhda Zozulya, MD PhD, Elena Likhachyova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3671.

https://doi.org/10.1182/blood.V130.Suppl_1.3671.3671

Published: 2017

Journal Articles

The Risk for Major Cardiovascular Event and Venous Thromboembolism in Patients with Factor VII and Factor V Deficiency.

Amir Warwar, MD, Antonio Kotler, MD, Shai Cohen, MD, Gad Rennert, MDPhD, Nili Stein, Meir Preis, MD PhD, Walid Saliba, MD

Blood (2017) 130 (Supplement 1): 1090.

https://doi.org/10.1182/blood.V130.Suppl_1.1090.1090

Published: 2017

Journal Articles

Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a

Davide Matino, MD, Antonella De Luca, PhD, Paolo Puccetti, MD, Francesca Fallarino, PhD, Alfonso Iorio, MD PhD

Blood (2017) 130 (Supplement 1): 1070.

https://doi.org/10.1182/blood.V130.Suppl_1.1070.1070

Published: 2017

Journal Articles

Factor VII Augusta (FVII G395D/G395N):Â a Compound Heterozygous Deletion Insertion and Missense Variant Manifesting As Moderate Bleeding Disorder

Afshin Ameri, MD, Rebecca S Parker, MD, Joetta H Smith, RN MSN

Blood (2017) 130 (Supplement 1): 2349.

https://doi.org/10.1182/blood.V130.Suppl_1.2349.2349

Published: 2017

Journal Articles

Activated Factor IX As a Candidate for the Initial Protease in the Coagulation Cascade

Tina M Misenheimer, PhD, Kraig T Kumfer, MD PhD, Barbara E Bates, MS, Brad S Schwartz, MD

Blood (2017) 130 (Supplement 1): 235.

https://doi.org/10.1182/blood.V130.Suppl_1.235.235

Published: 2017

Journal Articles

Preferential In Vitro and In Vivo Induction of Endogenous Retrovirus Transcription from a Monoallelic Chromosome 7q in Decitabine (DAC) Treated AML Blasts

Gabriele Greve, Dietmar Pfeifer, Sina Bengel, Michael Lübbert

Blood (2017) 130 (Supplement 1): 2612.

https://doi.org/10.1182/blood.V130.Suppl_1.2612.2612

Published: 2017

Journal Articles

Anticoagulation Therapy Considerations in Left Ventricular Assist Devices in the Setting of Factor VII Deficiency

Anuhya Kommalapati, MD, Sri Harsha Tella, MD, Allan-Louie Cruz, MD

Blood (2017) 130 (Supplement 1): 4898.

https://doi.org/10.1182/blood.V130.Suppl_1.4898.4898

Published: 2017

Journal Articles

Single Centre Retrospective Analysis of Patients Who Underwent Emergency Reversal of Warfarin Anticoagulation

Muhajir Bawa Mohamed, MDDM,FRACP,FRCPA,, Gerald Bates, Robert Hayes, Michael Morse, Ajay Prakash, Waheedha Basheer

Blood (2017) 130 (Supplement 1): 4913.

https://doi.org/10.1182/blood.V130.Suppl_1.4913.4913

Published: 2017

NARROW

Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study

Clinical, Laboratory and Molecular Characterization of Factor VII, Factor X and Their Combined Deficiencies in a Tertiary Care Center

Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes

Monitoring of Recombinant Activated Coagulation Factor VII (rFVIIa) Therapy in Patients (pts) with Inherited Factor VII (FVII) Deficiency

Barriers to Care Amongst Patients with Inherited Bleeding Disorders: Results from Two Nation-Wide Canadian Surveys

Platelet Function Disorder Is More Common Than Von Willebrand Disease in Women with Inherited Bleeding Disorders: Report from a Public Sector University in Pakistan

A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology

Replacing PT-INR Monitoring of Warfarin with Fiix-NR in Clinical Practice Reduces Thromboembolism without Increasing Bleeding Despite Reduced Number of Dose Adjustments

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Recombinant Activated Coagulation Factor VII (rFVIIa) for Treatment of the Tracheobronchial Bleeding in Mechanically Ventilated (MV) Thrombocytopenic Patients (pts)

The Chemical Chaperone 4-Phenylbutyrate Increases Secretion and Activity of Missense and Elongated Factor VII Mutants

Arsenic Trioxide Induces Apoptosis and Regulatory Functions of Plasmacytoid Dendritic Cells

Providing Hemostasis for Long-Term Central Venous Access Device (LTCVAD) Placement in Patients with Factor VIII (FVIII) Inhibitors

The Risk for Major Cardiovascular Event and Venous Thromboembolism in Patients with Factor VII and Factor V Deficiency.

Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a

Factor VII Augusta (FVII G395D/G395N):Â a Compound Heterozygous Deletion Insertion and Missense Variant Manifesting As Moderate Bleeding Disorder

Activated Factor IX As a Candidate for the Initial Protease in the Coagulation Cascade

Preferential In Vitro and In Vivo Induction of Endogenous Retrovirus Transcription from a Monoallelic Chromosome 7q in Decitabine (DAC) Treated AML Blasts

Anticoagulation Therapy Considerations in Left Ventricular Assist Devices in the Setting of Factor VII Deficiency

Single Centre Retrospective Analysis of Patients Who Underwent Emergency Reversal of Warfarin Anticoagulation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only